Eculizumab as a bridge to immunosuppressive therapy in severe cold agglutinin disease of anti‐Pr specificity

E-ISSN： 2050-0904|3|11|942-944

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.11, 2015-11, pp. : 942-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

By Garrood T. Scott D.L.

BioDrugs, Vol. 15, Iss. 8, 2001-08 ,pp. : 543-561

Adis International

Access to resources Recommend Favorite

The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease

By Reguiaï Ziad Grange Florent

American Journal of Clinical Dermatology, Vol. 8, Iss. 2, 2007-01 ,pp. : 67-77

Adis International

Access to resources Recommend Favorite

Developments in Inhaled Immunosuppressive Therapy for the Prevention of Pulmonary Graft Rejection

By Akamine S.

BioDrugs, Vol. 9, Iss. 1, 1998-01 ,pp. : 49-59

Adis International

Access to resources Recommend Favorite

Targeting Mitosis for Anti-Cancer Therapy

By Sudakin Valery

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

Gene Therapy in Infants with Severe Combined Immunodeficiency

By Otsu M. Candotti F.

BioDrugs, Vol. 16, Iss. 4, 2002-01 ,pp. : 229-239

Adis International

Access to resources Recommend Favorite